The DOSE index in chronic obstructive pulmonary disease: evaluating healthcare costs
The DOSE index demonstrates potential in predicting healthcare costs, particularly due to its inclusion of exacerbation frequency. This study highlights the importance of considering exacerbations alongside traditional risk factors for more accurate cost forecasting in COPD management. Our findings suggest that the DOSE index may be a valuable tool in both clinical and economic assessments of COPD patients, though further research is warranted to validate these findings in larger datasets.
Authors
- Chin-Ling Li (ORCID: https://orcid.org/0000-0003-3957-4522)
- Hui-Chuan Chang (ORCID: https://orcid.org/0000-0002-3020-4755)
- Shih‐Feng Liu (ORCID: https://orcid.org/0000-0003-1394-5401)
- Jui-Fang Liu (ORCID: https://orcid.org/0000-0002-1709-562X)
- Yuh-Chyn Tsai
- Chi‐Ming Chan (ORCID: https://orcid.org/0000-0002-3835-8345)
- Ching‐Wan Tseng
- Meng-Lin Tsai
Institutions
- Chang Gung University of Science and Technology (TW)
- National Sun Yat-sen University (TW)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s12890-024-03368-0
- Citations
- 4
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68